Key Insights

Highlights

Success Rate

67% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

18.2%

2 terminated out of 11 trials

Success Rate

66.7%

-19.9% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed with results

Key Signals

67% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
Early P 1 (1)

Trial Status

Completed4
Unknown2
Recruiting2
Terminated2
Not Yet Recruiting1

Trial Success Rate

66.7%

Benchmark: 86.6%

Based on 4 completed trials

Clinical Trials (11)

Research Network

Activity Timeline